Where GWAS and epidemiology meet: Opportunities for the simultaneous study of genetic and environmental risk factors in schizophrenia

Schizophrenia Bulletin

Volumn 39, Issue 5, 2013, Pages 955-959

  Mcgrath, John J ^a,b   Mortensen, Preben Bo ^c   Visscher, Peter M ^a   Wray, Naomi R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

epidemiology; genome wide association study; interaction; Mendelian randomization; polygene score

Indexed keywords

C REACTIVE PROTEIN;

ALLELE; ANXIETY DISORDER; ARTICLE; CONFOUNDING VARIABLE; CONTROL GROUP; DEPRESSION; DIZYGOTIC TWINS; ELECTRONIC MEDICAL RECORD; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; MAJOR DEPRESSION; MENDELIAN RANDOMIZATION ANALYSIS; MENTAL DISEASE; METABOLIC SYNDROME X; MONOZYGOTIC TWINS; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; SAMPLE SIZE; SAMPLING; SCHIZOPHRENIA; SECOND DEGREE RELATIVE; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EPIDEMIOLOGY; GENOME-WIDE ASSOCIATION STUDY; INTERACTION; MENDELIAN RANDOMIZATION; POLYGENE SCORE;

GENE-ENVIRONMENT INTERACTION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; SCHIZOPHRENIA;

EID: 84883479843     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt108     Document Type: Article

References (42)

1. Corvin A. Schizophrenia at a genetics crossroads: Where to now? Schizophr Bull. 2013;39:490-495
2. McGrath JJ, Lawlor DA. The search for modifiable risk factors for schizophrenia. Am J Psychiatry. 2011;168:1235-1238
3. Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678
4. Bergen SE, O'Dushlaine CT, Ripke S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17:880-886
5. Humphreys K, Grankvist A, Leu M, et al. The genetic structure of the Swedish population. PLoS One. 2011;6:e22547
6. Borglum AD, Demontis D, Grove J, et al. Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry. 2013. doi: 10.1038/mp.2013.2
7. Visscher PM, Hill WG, Wray NR. Heritability in the genomics era-concepts and misconceptions. Nat Rev Genet. 2008;9:255-266
8. Lichtenstein P, Björk C, Hultman CM, Scolnick E, Sklar P, Sullivan PF. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med. 2006;36:1417-1425
9. Yang J, Visscher PM, Wray NR. Sporadic cases are the norm for complex disease. Eur J Hum Genet. 2010;18:1039-1043
10. Do CB, Hinds DA, Francke U, Eriksson N. Comparison of family history and SNPs for predicting risk of complex disease. PLoS Genet. 2012;8:e1002973
11. Mortensen PB, Pedersen MG, Pedersen CB. Psychiatric family history and schizophrenia risk in Denmark: Which mental disorders are relevant? Psychol Med. 2010;40:201-210
12. Kendler KS. The impact of varying diagnostic thresholds on affected sib pair linkage analysis. Genet Epidemiol. 1988;5:407-419
13. Agerbo E, Mortensen PB, Wiuf C, et al. Modelling the contribution of family history and variation in single nucleotide polymorphisms to risk of schizophrenia: A Danish national birth cohort-based study. Schizophr Res. 2012;134:246-252
14. van Os J, Pedersen CB, Mortensen PB. Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. Am J Psychiatry. 2004;161:2312-2314
15. Genetic Risk and Outcome in Psychosis (GROUP) Investigators. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: An analysis of patient-sibling and sibling-control pairs. Arch Gen Psychiatry. 2011; 68:138-147
16. van Winkel R; Genetic Risk and Outcome in Psychosis) GROUP) Investigators. Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: Sibling analysis and proband follow-up. Arch Gen Psychiatry. 2011; 68:148-157
17. Wigman JT, van Winkel R, Ormel J, Verhulst FC, van Os J, Vollebergh WA. Early trauma and familial risk in the development of the extended psychosis phenotype in adolescence. Acta Psychiatr Scand. 2012;126:266-273
18. Svensson AC, Lichtenstein P, Sandin S, Öberg S, Sullivan PF, Hultman CM. Familial aggregation of schizophrenia: The moderating effect of age at onset, parental immigration, paternal age and season of birth. Scand J Public Health. 2012;40:43-50
19. Lenroot RK, Schmitt JE, Ordaz SJ, et al. Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence. Hum Brain Mapp. 2009;30:163-174
20. Bergen SE, Gardner CO, Kendler KS. Age-related changes in heritability of behavioral phenotypes over adolescence and young adulthood: A meta-analysis. Twin Res Hum Genet. 2007;10:423-433
21. Zammit S, Owen MJ, Lewis G. Misconceptions about geneenvironment interactions in psychiatry. Evid Based Ment Health. 2010;13:65-68
22. Zammit S, Lewis G, Dalman C, Allebeck P. Examining interactions between risk factors for psychosis. Br J Psychiatry. 2010;197:207-211
23. Duncan LE, Keller MC. A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry. 2011;168:1041-1049
24. van Winkel R, Henquet C, Rosa A, et al. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: An experience-sampling study. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B:10-17
25. van Winkel R; Genetic Risk and Outcome of Psychosis (GROUP) Investigators. Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: Sibling analysis and proband follow-up. Arch Gen Psychiatry. 2011;68:148-157
26. van Winkel R, Henquet C, Rosa A, et al. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: An experience-sampling study. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:10-17
27. Lee SH, DeCandia TR, Ripke S, et al. Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ); International Schizophrenia Consortium (ISC); Molecular Genetics of Schizophrenia Collaboration (MGS). Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet. 2012;44:247-250
28. Wray NR, Visscher PM. Narrowing the boundaries of the genetic architecture of schizophrenia. Schizophr Bull. 2010;36:14-23
29. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nat Rev Genet. 2012;13:537-551
30. Sullivan P; 96 Psychiatric Genetics Investigators. Don't give up on GWAS. Mol Psychiatry. 2012;17:2-3
31. Kohane IS, Drazen JM, Campion EW. A glimpse of the next 100 years in medicine. N Engl J Med. 2012;367:2538-2539
32. Perlis RH, Iosifescu DV, Castro VM, et al. Using electronic medical records to enable large-scale studies in psychiatry: Treatment resistant depression as a model. Psychol Med. 2012;42:41-50
33. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 2007;17:1520-1528
34. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752
35. Yang J, Benyamin B, McEvoy BP, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet. 2010;42:565-569
36. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88:294-305
37. Wheatley K, Gray R. Commentary: Mendelian randomization- an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. Int J Epidemiol. 2004;33:15-17
38. Smith GD, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1-22
39. Timpson NJ, Lawlor DA, Harbord RM, et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet. 2005;366:1954-1959
40. Bjørngaard JH, Gunnell D, Elvestad MB, et al. The causal role of smoking in anxiety and depression: A Mendelian randomization analysis of the HUNT study. Psychol Med. 2013;43:711-719
41. Smoller JW, Craddock N, Kendler K, et al. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet. 2013;381:1371-1379
42. Rappaport SM. Discovering environmental causes of disease. J Epidemiol Community Health. 2012;66:99-102